Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Lancet Neurology

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1474-4422(07)70178-3PMID 17616482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia.

  2007cited by this paper
• The effect of APOE genotype on clinical phenotype in Alzheimer disease.

  2007cited by this paper
• Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT.

  2007cited by this paper
• [11C]PIB in a nondemented population

  2006cited by this paper
• Alzheimer's Association Research Roundtable Meeting on Mild Cognitive Impairment: What have we learned?

  2006cited by this paper
• Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.

  2006cited by this paper
• Hippocampal atrophy in Alzheimer disease: Age matters

  2006cited by this paper
• Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI

  2006cited by this paper
• The effect of APOE genotype on clinical phenotype in Alzheimer disease

  2006cited by this paper
• Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers.

  2006cited by this paper
• Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease

  2006cited by this paper
• Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria.

  2006cited by this paper
• Potential antecedent marker of Alzheimer disease

  2006cited by this paper
• Mild cognitive impairment

  2006cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

  2006cited by this paper
• MRI evidence of bilateral hippocampal sclerosis in amnestic mild cognitive impairment

  2006cited by this paper
• Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.

  2006cited by this paper
• Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

  2006cited by this paper
• Frontotemporal dementia: Clinicopathological correlations

  2006cited by this paper
• Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

  2006cited by this paper
• Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans

  2006cited by this paper
• Mild cognitive impairment

  2005cited by this paper
• Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer’s disease

  2005cited by this paper
• Safety and Acceptability of the Research Lumbar Puncture

  2005cited by this paper
• MRI measures and progression of cognitive decline in nondemented elderly attending a memory clinic

  2005cited by this paper
• Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years

  2005cited by this paper
• Genetic factors in Alzheimer's disease.

  2005cited by this paper
• Editorial: advances in Alzheimer therapy: something old, something new, something borrowed, something blue.

  2005cited by this paper
• Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer’s disease?

  2005cited by this paper
• Clinical trials in mild cognitive impairment: lessons for the future

  2005cited by this paper
• Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B

  2005cited by this paper
• Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.

  2005cited by this paper
• CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.

  2005cited by this paper
• Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly

  2005cited by this paper
• A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment

  2005cited by this paper
• Vitamin E and donepezil for the treatment of mild cognitive impairment.

  2005cited by this paper
• Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.

  2005cited by this paper
• 11C-DTBZ and 18F-FDG PET measures in differentiating dementias.

  2005cited by this paper
• Frontotemporal dementia.

  2005cited by this paper
• Medial Temporal Lobe Atrophy and APOE Genotype Do Not Predict Cognitive Improvement upon Treatment with Rivastigmine in Alzheimer’s Disease Patients

  2005cited by this paper
• Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium

  2005cited by this paper
• Positron emission tomography diagnosis of Alzheimer's disease.

  2005cited by this paper
• Alzheimer disease: operating characteristics of PET--a meta-analysis.

  2004cited by this paper
• Amnestic MCI or prodromal Alzheimer's disease?

  2004cited by this paper
• MCI conversion to dementia and the APOE genotype

  2004cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• Detection and Management of Cognitive Impairment in Primary Care: The Steel Valley Seniors Survey

  2004cited by this paper
• Behavioral symptoms in mild cognitive impairment

  2004cited by this paper
• Frontotemporal lobar degeneration and ubiquitin immunohistochemistry

  2004cited by this paper
• Verbal memory performance of patients with a first depressive episode and patients with unipolar and bipolar recurrent depression.

  2004cited by this paper
• Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

  2004cited by this paper
• Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment

  2004cited by this paper
• Characterization of IMPY as a potential imaging agent for β-amyloid plaques in double transgenic PSAPP mice

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Mild cognitive impairment as a diagnostic entity

  2004cited by this paper
• Mild cognitive impairment: a cross-national comparison

  2004cited by this paper
• Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia.

  2004cited by this paper
• Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.

  2003cited by this paper
• CSF markers for incipient Alzheimer's disease.

  2003cited by this paper
• Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

  2003cited by this paper
• Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment

  2002cited by this paper
• Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

  2002cited by this paper
• Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

  2002cited by this paper
• Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.

  2002cited by this paper
• Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.

  2002cited by this paper
• Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits.

  2002cited by this paper
• Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.

  2002cited by this paper
• Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

  2002cited by this paper
• Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients.

  2002cited by this paper
• Hippocampal volume as an index of Alzheimer neuropathology: Findings from the Nun Study

  2002cited by this paper
• Incidence and outcome of mild cognitive impairment in a population-based prospective cohort

  2002cited by this paper
• Volumetric MRI Measurements Can Differentiate Alzheimer's Disease, Mild Cognitive Impairment, and Normal Aging

  2002cited by this paper
• Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study.

  2002cited by this paper
• Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation

  2001cited by this paper
• [Corticobasal degeneration].

  2001cited by this paper
• Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented.

  2001cited by this paper
• Accuracy of clinical criteria for AD in the Honolulu–Asia Aging Study, a population-based study

  2001cited by this paper
• MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

  2001cited by this paper
• SPECT perfusion imaging in the diagnosis of Alzheimer’s disease

  2001cited by this paper
• Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease

  2001cited by this paper
• Memory Impairment Differs in Frontotemporal Dementia and Alzhemier’s Disease.

  2001cited by this paper
• Inflammation, autotoxicity and Alzheimer disease.

  2001cited by this paper
• Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study

  2000cited by this paper
• Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease

  2000cited by this paper
• Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

  2000cited by this paper
• Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II

  2000cited by this paper
• Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

  2000cited by this paper
• Memory impairment on free and cued selective reminding predicts dementia

  2000cited by this paper
• Hippocampal volume reduction in major depression.

  2000cited by this paper
• Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented

  2000cited by this paper
• Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I

  2000cited by this paper
• Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease.

  2000cited by this paper
• Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease.

  1999cited by this paper
• MRI of entorhinal cortex in mild Alzheimer's disease.

  1999cited by this paper
• Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

  1999cited by this paper
• Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease.

  1999cited by this paper
• Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF

  1999cited by this paper
• Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series

  1999cited by this paper
• Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia

  1999cited by this paper
• Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment

  1999cited by this paper

• A Lightweight Dual-Branch Multi-Level Attentive Attributes With Constraint Fusion Network for EEG-Based Alzheimer’s Detection

  2026cites this paper
• An integrative multi-omics study reveals glutamine metabolism dysregulation connecting Alzheimer's disease and age-related macular degeneration.

  2026cites this paper
• Architectural Constraints in LLM-Simulated Cognitive Decline: In Silico Dissociation of Memory Deficits and Generative Language as Candidate Digital Biomarkers

  2026cites this paper
• The immunomodulating effect of palmitoylethanolamide on human myeloid dendritic cells and its possible impact on Alzheimer’s disease

  2026cites this paper
• Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areas.

  2026cites this paper
• Trajectory of stratum radiatum, lacunosum and moleculare integrity in Alzheimer’s disease continuum

  2026cites this paper
• Harmonized Protocol for Subfield Segmentation in the Hippocampal Body on High‐Resolution In Vivo MRI From the Hippocampal Subfields Group (HSG)

  2026cites this paper
• Ethnic‐specific effects of the LILRB2–LILRB5 locus and newly identified risk loci for Alzheimer's disease in the East Asian population

  2026cites this paper
• ACR–ACNM–ASNR–SNMMI Practice Parameter for the Performance of Brain PET/CT Imaging in Dementia

  2026cites this paper
• Impact of Cerebral Microbleeds on Tau-Associated Cognitive and Structural Decline.

  2026cites this paper
• Systematic review of Free and Cued Selective Reminding Test with Immediate Recall (FCSRT-IR) studies: normative data, clinical validity, and correlations with biomarkers

  2026cites this paper
• EMAD: Evidence-Centric Grounded Multimodal Diagnosis for Alzheimer's Disease

  2026cites this paper
• Follicle-stimulating hormone linked to cognitive decline and amyloid burden in postmenopausal women

  2026cites this paper
• Soluble and plaque amyloid associations with peripheral glucose dysregulation modulated by tau pathology in Alzheimer’s disease

  2026cites this paper
• Evaluating the association of apolipoprotein E genotype and cognitive resilience in SuperAgers

  2026cites this paper
• Patterns of cognitive and motor decline in Alzheimer’s Disease (AD) and ageing in healthy populations

  2026cites this paper
• Gradient magnitude-based texture feature of the entorhinal cortex as a biomarker for Alzheimer's disease.

  2026cites this paper
• Value of lncRNA LINC00641 as a Potential Biomarker for Diagnosis of Alzheimer’s Disease and Elucidation of its Underlying Molecular Mechanism

  2026cites this paper
• PICALM Genetic Variant Alters mRNA Expression Without Affecting Protein Levels or Tau Spreading in Alzheimer’s Disease

  2026cites this paper
• Moderating effect of the domains of the cognitive reserve index questionnaire (CRIq) on longitudinal change slopes in episodic memory across the cognitive aging continuum

  2026cites this paper
• Soluble SORL1 in cerebrospinal fluid as a marker for functional impact of rare SORL1 variants

  2026cites this paper
• Dual-Transformer Cross-Attention Framework for Alzheimer's disease detection via dPTE-Guided EEG channel selection and multi-modal integration

  2026cites this paper
• Tau PET imaging as a mediator between glymphatic dysfunction and cognitive decline: a cross-sectional and longitudinal study.

  2026cites this paper
• HCG18 is a Potential Pathogenic Factor and Diagnostic Biomarker Alzheimer’s Disease

  2026cites this paper
• Isolated medial temporal lobe amnesia (MTLA): Predictor of cerebral amyloidosis or marker of phenotype-specific vulnerability?

  2026cites this paper
• Simultaneous Analysis of Microsaccades and Pupil Size Variations in Age-Related Cognitive Impairment Using Eye-Tracking Technology

  2026cites this paper
• A multi-route chemiluminescent probe for real-time imaging of β-amyloid pathology in Alzheimer's disease.

  2025cites this paper
• Deterioration of Lexical Processing in Older Chinese Adults With Alzheimer's Disease: Insights From Reading Chinese Compounds.

  2025cites this paper
• Distinct glial functions are associated with Alzheimer's disease based on cell-type- and pathway-specific polygenic risk score analysis

  2025cites this paper
• Task-based fMRI brain activation in mild cognitive impairment and Alzheimer's disease: an ALE meta-analysis.

  2025cites this paper
• A bayesian network model for neurocognitive disorders digital screening in Chinese population: development and validation study

  2025cites this paper
• Exosomal miRNA biomarkers in Alzheimer's disease: Systematic review and meta-analysis.

  2025cites this paper
• Differential cued recall memory impairment in mild cognitive impairment due to Alzheimer's disease versus Parkinson's disease.

  2025cites this paper
• Bowel Health, Laxative Use, and Cognitive Function in Older Puerto Rican Adults

  2025cites this paper
• The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer’s Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression

  2025cites this paper
• Differential effects of soluble and plaque amyloid on late-life depression: The moderating role of tau pathology

  2025cites this paper
• From Amyloid to Synaptic Dysfunction: Biomarker-Driven Insights into Alzheimer’s Disease

  2025cites this paper
• Faster decline of very prodromal dementia with Lewy bodies when amyloid positive

  2025cites this paper
• Cerebellar MRI-based radiomics models for identifying mild cognitive impairment: a retrospective multicenter study in Southeast China

  2025cites this paper
• Diagnostic and inclusion criteria in Alzheimer's disease clinical trials: A systematic review of the past decade

  2025cites this paper
• A passive and objective measure of recognition memory in mild cognitive impairment using Fastball memory assessment

  2025cites this paper
• Detection of clinical Alzheimer's disease in diverse populations: Contribution of a delayed recall to the TNI-93.

  2025cites this paper
• Musical Engagement of brain LObes in Alzheimer's Disease patients study (MELODY): A randomized controlled trial.

  2025cites this paper
• A Separable Bi-Pyramidal Feature Attention Network to Detect Alzheimer’s Using Electroencephalographic Signals

  2025cites this paper
• Clinical phenotypes of Alzheimer’s disease: investigating atrophy patterns and their pathological correlates

  2025cites this paper
• Training Autobiographical Memory in Older Adults using Photos from Wearable Cameras.

  2025cites this paper
• Multilayer Integration of Networks Toolbox (MINT)

  2025cites this paper
• Diagnostic performance of plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non‐AD dementias: An international multi‐center study

  2025cites this paper
• Neuromodulatory role and therapeutic potential of N6-methyladenosine RNA methylation in neurodegenerative diseases.

  2025cites this paper
• CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer’s disease patients

  2025cites this paper
• Development and Concurrent Validation of a Retrogenetic Instrument for the Assessment of Activities of Daily Living: The Functional Assessment Scale of the Barcelona Test.

  2025cites this paper
• Cognitive Resilience in Apolipoprotein ε4 Carrier Women Predicted by Neuron‐Derived Extracellular Vesicles

  2025cites this paper
• Circulating Biomarkers for the Early Diagnosis of Alzheimer’s Disease

  2025cites this paper
• Quantitative assessment of brain glymphatic imaging features using deep learning-based EPVS segmentation and DTI-ALPS analysis in Alzheimer’s disease

  2025cites this paper
• The biological diagnosis of Alzheimer's disease using blood-based biomarkers: A Canadian prospective.

  2025cites this paper
• Identification of novel candidate loci for Alzheimer’s disease and related dementias by leveraging the shared genetic basis with hippocampal volume

  2025cites this paper
• Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives

  2025cites this paper
• Sex differences in white matter amplitude of low-frequency fluctuation associated with cognitive performance across the Alzheimer's disease continuum

  2025cites this paper
• Understanding the role of microglia in Alzheimer's disease: insights into mechanisms, acupuncture, and potential therapeutic targets.

  2025cites this paper
• Nasal Aβ42 mirrors brain amyloid dynamics and cognitive decline across the Alzheimer’s disease continuum

  2025cites this paper
• The Alzheimer's Disease Continuum - A New Diagnostic Approach.

  2025cites this paper
• Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia

  2025cites this paper
• Cognitive and neuroimaging outcome of very prodromal dementia with Lewy bodies.

  2025cites this paper
• Efficacy and Safety of Bilateral Deep Brain Stimulation (DBS) for Severe Alzheimer's Disease: A Comparative Analysis of Fornix Versus Basal Ganglia of Meynert

  2025cites this paper
• Differential involvement of neurotransmitter pathways in AD, bvFTD and MCI: Whole-brain MRI analysis.

  2025cites this paper
• Impact of obesity on neuropsychiatric symptoms in Alzheimer's disease: Insights from the ADNI cohort

  2025cites this paper
• Impact of combined art-based intervention on functional connectivity of multiple brain networks in older adults along the cognitive continuum: result from a parallel randomised controlled trial

  2025cites this paper
• Iron Overload, Microbleeding and the Role of Bilirubin in Alzheimer’s Disease Brain: Revisiting the Vascular Hypothesis

  2025cites this paper
• Diagnostic performance of deep learning-assisted [18F]FDG PET imaging for Alzheimer’s disease: a systematic review and meta-analysis

  2025cites this paper
• Repeated neuromodulation with low-intensity focused ultrasound in patients with Alzheimer's disease

  2025cites this paper
• How can we define a brain health chart? A narrative review and a proposal

  2025cites this paper
• Examining the effects of extremely low-frequency magnetic fields on cognitive functions and functional brain markers in aged mice

  2025cites this paper
• Artificial intelligence in insanity evaluation. Potential opportunities and current challenges.

  2025cites this paper
• Hybrid multi-modality multi-task learning for forecasting progression trajectories in subjective cognitive decline

  2025cites this paper
• Neuropsychology of Alzheimer's disease: From preclinical phase to dementia.

  2025cites this paper
• Biofilm-Associated Amyloid Proteins Linked with the Progression of Neurodegenerative Diseases

  2025cites this paper
• A higher vertebrobasilar pulsatility index is associated with lower parietal perfusion in Alzheimer's disease

  2025cites this paper
• Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients

  2025cites this paper
• Social cognition in mild cognitive impairment and dementia: A systematic review and meta‐analysis

  2025cites this paper
• Blood biomarkers for clinical applications in Alzheimer's disease: A narrative review

  2025cites this paper
• Gadolinium based contrast agent induced electrical conductivity heterogeneity analysis in the brain of Alzheimer’s disease

  2025influential citation
• Plasma protein risk scores for mild cognitive impairment and Alzheimer's disease in the Framingham heart study

  2025cites this paper
• Development and validation of a harmonized memory score for multicenter Alzheimer’s disease and related dementia research

  2025cites this paper
• Quantitative magnetic resonance imaging in Alzheimer’s disease: a narrative review

  2025cites this paper
• Changing definitions of disease: Transformations in the diagnostic criteria for Alzheimer's disease

  2025influential citation
• Mechanisms of the Pathogenesis of Alzheimer’s Disease: The Role of the Basal Forebrain

  2025cites this paper
• Neural correlates of subjective cognitive decline in Alzheimer’s disease: a systematic review of structural and functional brain changes for early diagnosis and intervention

  2025cites this paper
• Variants in Neurotransmitter-Related Genes Are Associated with Alzheimer’s Disease Risk and Cognitive Functioning but Not Short-Term Treatment Response

  2025cites this paper
• HoloDx: Knowledge- and Data-Driven Multimodal Diagnosis of Alzheimer’s Disease

  2025cites this paper
• Diagnostic performance of self-administered unsupervised computerized cognitive tests for the identification of mild cognitive impairment (MCI) and dementia: a systematic review and meta-analysis

  2025cites this paper
• Modern biomarkers as key tools in the early diagnosis and monitoring of Alzheimer's disease progression

  2025influential citation
• Harmonized Protocol for Subfield Segmentation in the Hippocampal Body on High-Resolution in vivo MRI from the Hippocampal Subfields Group (HSG)

  2025cites this paper
• An Interpretable Deep Learning Approach for Alzheimer's Disease Diagnosis Using Gene Expression Data

  2025cites this paper
• AI-based staging, causal hypothesis and progression of subjects at risk of Alzheimer’s disease: a multicenter study

  2025cites this paper
• Multisite chronic pain: association with cognitive decline and post-mortem Alzheimer’s biomarkers

  2025cites this paper
• Gray Matter and White Matter Functional Connectivity Changes induced by rTMS concurrent with Cognitive training in Alzheimer's disease.

  2025cites this paper
• Connectogram-COH: A Coherence-Based Time-Graph Representation for EEG-Based Alzheimer’s Disease Detection

  2025cites this paper
• The dynamics of cognitive decline toward Alzheimer's disease progression: Results from ADSP‐PHC's harmonized cognitive composites

  2025cites this paper
• Neural Network-Enhanced Investigation of Ferroptosis and Druggability in Early-Onset Alzheimer’s Disease

  2025cites this paper
• Neurovascular Decoupling Is Associated With Lobar Intracerebral Hemorrhages and White Matter Hyperintensities

  2025cites this paper